Mallinckrodt to pay $15M to resolve whistleblower allegations

Mallinckrodt has agreed to pay $15.4 million to resolve whistleblower allegations that the drugmaker paid physicians illegal kickbacks to boost prescriptions of its pricey H.P. Acthar Gel, the U.S. Justice Department said.

The alleged misconduct was by 12 sales representatives from Questcor Pharmaceuticals, which Mallincrodt acquired in August 2014. 

Prosecutors claim that the drugmaker, between 2009 and 2013, "wined and dined" physicians in order to improve Medicare prescription rates and boost profits. The alleged acts, which resulted in false claims being submitted to Medicare, are a violation of the federal Anti-Kickback Statute and the False Claims Act. 

Read the full news release here. 

More articles on pharmacy:
Civica Rx says it isn't afraid of competition
Cigna rolls out plan to fully cover expensive gene therapies
Rutgers to close 3 on-campus pharmacies

© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.


Featured Content

Featured Webinars

Featured Whitepapers